PODD Oct 2024 175.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
At close: 03:54PM EDT
| Previous close | 22.50 |
| Open | 30.50 |
| Bid | 29.30 |
| Ask | 31.70 |
| Strike | 175.00 |
| Expiry date | 2024-10-18 |
| Day's range | 30.50 - 30.50 |
| Contract range | N/A |
| Volume | |
| Open interest | 11 |
Simply Wall St.Here's Why We Think Insulet (NASDAQ:PODD) Is Well Worth Watching
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...
Barrons.comThis Healthcare Stock Is the Best Performer in the S&P 500 After FDA Approval
Insulet stock was surging Tuesday after the healthcare company said its Omnipod 5 Insulin System got approval from the Food and Drug Administration. Insulet said in a news release Tuesday that its Omnipod 5 Automated Insulin Delivery System has been cleared by the FDA for use by people over 18 with Type 2 diabetes. The Omnipod 5 is an insulin delivery system that is used to manage blood sugar levels.
ZacksInsulet's Omnipod 5 Wins FDA Approval for Type 2 Diabetes
PODD marks a major milestone with Omnipod 5 approval for the treatment of type 2 diabetes.
© 2024 Yahoo. All rights reserved.